NexgenRx Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NEGXF research report →
Companywww.nexgenrx.com
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers prescription drug claims; dental claims; and claims for the extended health benefits, as well as a health care spending account that provides an amount of money to an individual to pay for health or dental benefits.
- CEO
- Ronald C. Loucks
- IPO
- 2017
- Employees
- 20
- HQ
- Toronto, ON, CA
Price Chart
Valuation
- Market Cap
- $19.20M
- P/E
- 20.43
- P/S
- 1.47
- P/B
- 3.46
- EV/EBITDA
- -1.34
- Div Yield
- 4.03%
Profitability
- Gross Margin
- 80.07%
- Op Margin
- 12.70%
- Net Margin
- 7.18%
- ROE
- 16.07%
- ROIC
- 19.09%
Growth & Income
- Revenue
- $17.46M · 5.99%
- Net Income
- $1.29M · 109.69%
- EPS
- $0.01 · 150.00%
- Op Income
- $1.78M
- FCF YoY
- -118.01%
Performance & Tape
- 52W High
- $0.28
- 52W Low
- $0.19
- 50D MA
- $0.27
- 200D MA
- $0.24
- Beta
- 0.45
- Avg Volume
- 163
Get TickerSpark's AI analysis on NEGXF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our NEGXF Coverage
We haven't published any research on NEGXF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NEGXF Report →